Dr. Christopher T. Chen

  • Radiation Oncologist
  • Spoken languages English


Dr. Christopher Chen makes individualized patient care his highest priority. In addition to patient care, he has been actively involved in both clinical and basic science cancer research throughout his career. He is currently a Clinical Assistant Professor at Nova Southeastern University College of Medicine (Affiliate). He serves as a National Cancer Institute (NCI) site investigator for RTOG/NRG Oncology. Dr. Chen has contributed to numerous abstracts and journal publications on radiation therapy and novel cancer treatments. He has been invited to present this data at a number of national and international meetings. Additionally, he has authored several textbook chapters in the field. Dr. Chen has served as the Physician Advisor to the American Cancer Society as well as the Medical Executive Committee and also served on the Medical Executive Committee at the Cleveland Clinic. He is a member of various committees for both the American College of Radiation Oncology (ACRO) and American Society for Therapeutic Radiology & Oncology (ASTRO) as well.

Career Positions

Current position(s)

  • GenesisCare - Radiation Oncologist



  • Pennsylvania State University, University Park
  • Jefferson Medical College, Doctor of Medicine, Philadelphia, PA


  • Thomas Jefferson University Hospital, Radiation Oncology, Chief Resident, Philadelphia, PA
  • Subspecialty Training, Hospital of the University of Pennsylvania, Philadelphia, PA


  • Mercy Catholic Medical Center, Internal Medicine, Darby, PA

Expertise And Interests


  • Prostate, Breast, Lung, Colorectal, Head and Neck Malignancies


Awards and honors

  • Radiological Society of North America (RSNA) Roentgen Research Award (2x recipient), American Radium Society Young Investigator Award, Hyman Menduke Prize, Jefferson Medical College, for Clinical and Basic Science Research


  • Multicenter Assessment of Stereotactic Body Radiation Therapy (SBRT) Boost in Intermediate-Risk Prostate Cancer: Biochemical Failure and Toxicity

Clinical studies

This is a prospective cohort study for patients diagnosed with ductal carcinoma in situ (DCIS) of the breast. The primary objective of the study is to create a de-identified database of patients, test results, treatment decisions and outcomes that can be queried to determine the utility of the DCISionRT™ test in the diagnosis and treatment of ductal carcinoma in situ of the breast.

View Study

Christopher Chen's Reviews


based on 127 Ratings 26 Comments


I was there for an intake appointment. I was there for 2 hours. I spent nearly all of that time simply waiting. I feel that I was kept waiting far too long.


Confirm the appointment would be nice. it was a very professional environment and kind.


I found everthing very Satis. No complaints


I was completely satisfied thanks very much

Read More

Ratings and Comments Powered by NRC Health